Dermata Therapeutics, Inc. - Common Stock (DRMA)
1.3500
+0.0500 (3.85%)
Dermata Therapeutics Inc is a biotechnology company focused on developing innovative therapeutics for skin diseases and conditions
The company leverages its proprietary technology platform to create treatments that aim to improve patient outcomes in dermatology. Dermata Therapeutics is committed to addressing unmet medical needs and advancing its product candidates through various stages of clinical development. By prioritizing research and development, the company seeks to bring forward effective solutions for skin health and enhance the quality of life for individuals affected by dermatological disorders.

Via Benzinga · September 17, 2024

Via Benzinga · September 16, 2024

Via Benzinga · September 16, 2024

Via Benzinga · August 21, 2024

Dermata Therapeutics stock is up on Wednesday with heavy trading of the company's shares despite a lack of news this morning.
Via InvestorPlace · July 24, 2024

If your growth stocks have stopped growing then you may be holding on to F-rated growth stocks. It's time to sell.
Via InvestorPlace · August 9, 2024

DRMA stock results show that Dermata Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 7, 2024

Pre-market stock movers are a hot topic on Thursday morning and we have all of the latest news traders need to know about them!
Via InvestorPlace · July 25, 2024

Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares are trading higher Wednesday. Here's what you need to know.
Via Benzinga · July 24, 2024

Via Benzinga · July 24, 2024

Azitra stock is falling on Wednesday as shares of AZTR come off of a massive rally yesterday alongside a new patent update.
Via InvestorPlace · July 24, 2024

Nuzee stock is up on Wednesday with heavy trading of NUZE shares despite a lack of news from the coffee machine company.
Via InvestorPlace · July 24, 2024

It's time to dive into the biggest pre-market stock movers for Wednesday as we check out all of the hottest news to start the day with!
Via InvestorPlace · July 24, 2024

Via Benzinga · July 24, 2024

Via Benzinga · May 28, 2024

Via Benzinga · July 23, 2024

DRMA stock results show that Dermata Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 15, 2024

Via Benzinga · May 14, 2024

It's time to start the trading week with a breakdown of the biggest pre-market stock movers worth watching on Monday morning!
Via InvestorPlace · May 13, 2024

Via Benzinga · May 10, 2024

Via Benzinga · April 22, 2024

It's time to start ofd the trading week with a look at the biggest pre-market stock movers traders need to watch on Monday morning!
Via InvestorPlace · April 22, 2024

Via Benzinga · April 16, 2024